Dr Serge Cremers appointed Editor-in-Chief of British Journal of Clinical Pharmacology

The British Pharmacological Society has appointed Dr Serge Cremers as the new Editor-in-Chief of the British Journal of Clinical Pharmacology.

Dr Cremers is Director of Columbia University Medical Center’s Clinical Pharmacology and Toxicology Laboratory and Director of the Biomarkers Core Laboratory at the Irving Institute for Clinical and Translational Research. He has been Reviews Senior Editor for the Journal since January 2017. He has led the Reviews Board and developed a programme of high-impact commissioned reviews and themed issues.

Dr Cremers will begin the role in January 2020, taking over from the outgoing Editor-in-Chief, Professor Adam Cohen. Speaking about the appointment, Professor Cohen said:

"To be Editor-in Chief of the British Journal of Clinical Pharmacology is to have the privilege of being in one of the most inspiring positions in the field. From this unique vantage point, you can see what colleagues all over the world are up to and assist in making their findings public. This - along with the incredibly good relations with my fellow editors and publisher - will be something I shall miss. But it gives me enormous pleasure that my post is taken by Serge, who will without any doubt take the journal into a bright future."

Dr Cremers said:

"I am honoured to be selected as the next Editor-in-Chief of the British Journal of Clinical Pharmacology. During his term, Professor Cohen has deepened the Journal’s connections with colleagues all over the world, strengthened the Editorial Board and overseen a considerable growth in submissions. I look forward to building on Adam’s work to attract even more high-level original work from academia, regulatory authorities and industry, and to incorporate more new developments into publications such as precision medicine and artificial intelligence."

The Society’s President-Elect, Professor Sir Munir Pirmohamed, who led the recruitment panel, said:

"The British Journal of Clinical Pharmacology serves a key purpose to the Society, in promoting and progressing the field of clinical pharmacology and therapeutics. At a time when the ways in which research is published and shared are changing, the Journal needs a bold vision for the future. I am confident that Serge, supported by our Editors and our publisher, will successfully guide the Journal through the years ahead."

NOTES

  1. The British Pharmacological Society is a charity with a mission to promote and advance the whole spectrum of pharmacology. Founded in 1931, it is now a global community at the heart of pharmacology, with around 4,000 members from more than 60 countries worldwide.
  2. The British Journal of Clinical Pharmacology (BJCP) contains papers and reports on all aspects of drug action in humans: invited review articles, original papers and correspondence. The journal enjoys a wide readership, bridging the gap between the medical profession, clinical research and the pharmaceutical industry.
  3. BJCP is published monthly, and is available online at:  https://bpspubs.onlinelibrary.wiley.com/journal/13652125

Back to listing